Skip to content
10-Q/A

Quarterly Report

VSee Health, Inc. VSEE VSEEW

0001185185-25-001818

← back to feed
Filed
Nov 20, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Oct 14, 2025 17.02M sh
Shares Diluted Q2 2025 · Jun 30, 2025 16.42M sh
Shares Diluted restated Q2 2025 · Jun 30, 2025 16.37M sh
Shares Diluted Q2 2025 · Jun 30, 2024 5.3M sh
Shares Diluted Q2 2025 · Jun 30, 2024 4.97M sh
Capex Q2 2025 · Jun 30, 2025 $15.47K
Capex Q2 2025 · Jun 30, 2024 $45.51K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$765.09K
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.59M
Long Term Debt Q2 2025 · Jun 30, 2025 $593.94K
Long Term Debt Q2 2025 · Dec 31, 2024 $593.94K
Short Term Debt restated Q2 2025 · Jun 30, 2025 $1.46M
Short Term Debt Q2 2025 · Dec 31, 2024 $433.98K
Cash And Equivalents Q2 2025 · Jun 30, 2025 $291.6K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $326.12K
Stockholders Equity restated Q2 2025 · Jun 30, 2025 −$5.74M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$18.49K
Current Liabilities restated Q2 2025 · Jun 30, 2025 $23.06M
Current Liabilities Q2 2025 · Dec 31, 2024 $19.01M
Current Liabilities restated Q2 2025 · Jun 30, 2024 $24.12M
Total Liabilities restated Q2 2025 · Jun 30, 2025 $23.95M
Total Liabilities Q2 2025 · Dec 31, 2024 $20.01M
Total Liabilities restated Q2 2025 · Jun 30, 2024 $25.48M
Current Assets Q2 2025 · Jun 30, 2025 $2.56M
Current Assets Q2 2025 · Dec 31, 2024 $3.02M
Current Assets restated Q2 2025 · Jun 30, 2024 $3.08M
Total Assets Q2 2025 · Jun 30, 2025 $18.21M
Total Assets Q2 2025 · Dec 31, 2024 $19.99M
Total Assets restated Q2 2025 · Jun 30, 2024 $78.59M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.16
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.40
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.12
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.11
Eps Basic Q2 2025 · Jun 30, 2025 −$0.16
Eps Basic Q2 2025 · Jun 30, 2025 −$0.40
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.12
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.11
Sga Expense Q2 2025 · Jun 30, 2025 $2.17M
Sga Expense Q2 2025 · Jun 30, 2025 $4.21M
Sga Expense restated Q2 2025 · Jun 30, 2024 $568.47K
Sga Expense restated Q2 2025 · Jun 30, 2024 $779.24K
Net Income Q2 2025 · Jun 30, 2025 −$2.61M
Net Income Q2 2025 · Jun 30, 2025 −$6.57M
Net Income restated Q2 2025 · Jun 30, 2024 −$634.12K
Net Income restated Q2 2025 · Jun 30, 2024 −$571.35K
Operating Income Q2 2025 · Jun 30, 2025 −$2.25M
Operating Income Q2 2025 · Jun 30, 2025 −$4.09M
Operating Income restated Q2 2025 · Jun 30, 2024 −$932.52K
Operating Income restated Q2 2025 · Jun 30, 2024 −$828.46K
Gross Profit Q2 2025 · Jun 30, 2025 $1.59M
Gross Profit Q2 2025 · Jun 30, 2025 $3.45M
Gross Profit restated Q2 2025 · Jun 30, 2024 $777K
Gross Profit restated Q2 2025 · Jun 30, 2024 $2.01M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $1.8M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.26M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $934.57K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.32M
Revenue Q2 2025 · Jun 30, 2025 $3.39M
Revenue Q2 2025 · Jun 30, 2025 $6.71M
Revenue Q2 2025 · Jun 30, 2024 $1.71M
Revenue restated Q2 2025 · Jun 30, 2024 $3.33M